000043826 000__ 01021cam\a22003135i\4500
000043826 001__ 43826
000043826 005__ 20240708150012.0
000043826 006__ m\\\\eo\\d\\\\\\\\
000043826 007__ cr bn |||m|||a
000043826 008__ 210615s2020\\\\sz\\\\\\\\\\\\000\0\eng\d
000043826 035__ $$a(OCoLC)1284950927
000043826 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000043826 041__ $$aeng
000043826 24500 $$aNonobviousness Standard For Promoting Ongoing Drug Discovery :$$ba Lesson From Sanofi-aventis U.s., Llc V. Dr. Reddy’s Laboratories, Inc.
000043826 264_1 $$a[Chicago, Illinois] :$$bUIC Review of Intellectual Property Law,$$c2020
000043826 300__ $$a1 online resource (pages 1-30)
000043826 337__ $$aunmediated$$bn$$2rdamedia
000043826 4901_ $$aJohn Marshal Review of Intellectual Property Law,$$x1930-8140 ;$$vVolume 20, Issue 1, 2020, pp. 1-30
000043826 542__ $$fhttps://repository.law.uic.edu/cgi/viewcontent.cgi?article=1485&context=ripl
000043826 588__ $$aCrossref
000043826 590__ $$aPublished online: 2020
000043826 650_0 $$aIntellectual property.
000043826 7001_ $$aChen, Ping-hsun,$$eauthor.
000043826 7730_ $$tJohn Marshal Review of Intellectual Property Law$$wJMR
000043826 830_0 $$aJohn Marshal Review of Intellectual Property Law ;$$vVolume 20, Issue 1, 2020, pp. 1-30.
000043826 85641 $$uhttps://repository.law.uic.edu/cgi/viewcontent.cgi?article=1485&context=ripl$$yonline version
000043826 904__ $$aJournal article
000043826 980__ $$aJMR